Update on AUA guideline on the management of benign prostatic hyperplasia. - Wikidata - awgldk - TriplyDB

Update on AUA guideline on the management of benign prostatic hyperplasia.

Update on AUA guideline on the management of benign prostatic hyperplasia.

http://www.wikidata.org/entity/Q44411654

about

Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction Microwave thermotherapy for benign prostatic hyperplasia Apoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic Hyperplasia Nocturia: The circadian voiding disorder Use of Botulinum Toxin A in the Treatment of Lower Urinary Tract Disorders: A Review of the Literature Recent advances in treatment for Benign Prostatic Hyperplasia Korean clinical practice guideline for benign prostatic hyperplasia Fixed-dose combination therapy with dutasteride and tamsulosin in the management of benign prostatic hyperplasia Clinical and preclinical treatment of urologic diseases with phosphodiesterase isoenzymes 5 inhibitors: an update A critical review of recent clinical practice guidelines on the diagnosis and treatment of non-neurogenic male lower urinary tract symptoms Efficacy and safety of muscarinic antagonists as add-on therapy for male lower urinary tract symptoms Update on medical therapy for male LUTS Holmium laser enucleation versus transurethral resection in patients with benign prostate hyperplasia: an updated systematic review with meta-analysis and trial sequential analysis Combination of tadalafil and finasteride for improving the symptoms of benign prostatic hyperplasia: critical appraisal and patient focus Lifestyle and lower urinary tract symptoms: what is the correlation in men?Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods (UPSTREAM) for diagnosis and management of bladder outlet obstruction in men: study protocol for a randomised controlled trial.Holmium laser enucleation of the prostate: patient selection and perspectives Ejaculatory dysfunction in the treatment of lower urinary tract symptoms Comparative effectiveness of oral drug therapies for lower urinary tract symptoms due to benign prostatic hyperplasia: a systematic review and network meta-analysis Drug interactions between antiretrovirals and drugs used to treat benign prostatic hyperplasia/lower urinary tract symptoms.Role of Acoustic Radiation Force Impulse (ARFI) Elastography in Determination of Severity of Benign Prostate Hyperplasia The effect of increasing doses of saw palmetto fruit extract on serum prostate specific antigen: analysis of the CAMUS randomized trial Prostate histotripsy: evaluation of prostatic urethral treatment parameters in a canine model Combined low-frequency ultrasound and microbubble contrast agent for the treatment of benign prostatic hyperplasia.Urethral-sparing histotripsy of the prostate in a canine model.Endoscopic assessment and prediction of prostate urethral disintegration after histotripsy treatment in a canine model Moxibustion as an adjuvant for benign prostatic hyperplasia with lower urinary tract symptoms: a protocol for a parallel-group, randomised, controlled pilot trial.A pooled analysis of individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH).Individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH): subgroup analyses of efficacy and safety data.Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.Can we use baseline characteristics to assess which men with moderately symptomatic benign prostatic hyperplasia at risk of progression will benefit from treatment? A post hoc analysis of data from the 2-year CONDUCT study.Measuring change in prostate size after holmium laser enucleation: A prospective study.Development of Decision Support Formulas for the Prediction of Bladder Outlet Obstruction and Prostatic Surgery in Patients With Lower Urinary Tract Symptom/Benign Prostatic Hyperplasia: Part I, Development of the Formula and its Internal Validation Radical prostatectomy improves and prevents age dependent progression of lower urinary tract symptoms Increased detrusor collagen is associated with detrusor overactivity and decreased bladder compliance in men with benign prostatic obstruction.Finasteride reduces the risk of incident clinical benign prostatic hyperplasia (-)Doxazosin is a necessary component for the hypotensive effect of (±)doxazosin during long-term administration in conscious rats Sociodemographic Factors Related to Lower Urinary Tract Symptoms in Men: A Korean Community Health Survey The burden of prostatic calculi is more important than the presence.Initial treatment of men with newly diagnosed lower urinary tract dysfunction in the Veterans Health Administration

P2860

Q24186736-6CEDC6ED-88B2-4897-A551-AB6D949E3E42 Q24200487-4113AF42-0F59-4056-A9BA-235EFB102F8E Q26741226-164D7CC7-C7B4-4135-9642-E8FDFC7399AA Q26747755-D484D6D3-49F0-4BEB-9D93-AD169A180815 Q26749613-A135ECDF-AF79-47E7-B18B-6B16BBD6304B Q26766218-EA139018-064F-4089-8D57-4475EB21DD09 Q26766302-6E15F70E-784B-42BD-9423-5F7FDDC4AF00 Q26770425-4F90F5EB-ECA0-4C71-B9F7-47AB9B0EB4E2 Q26775925-EC69A4C7-CA0F-45A1-8410-64342CBCB191 Q26798012-0048DDFE-9F77-4869-99B0-45ABC6A59287 Q26825032-3FDB8E96-6D3C-4BF0-B3A2-F13F09F5CB7D Q26862710-72C70E4E-A10D-4F64-8C7E-313037C3BD5A Q26991636-BE241284-2B70-4B05-A192-A9E9EF49F835 Q27008847-1665B066-AEA1-414D-A033-15908E53871E Q27024195-4193D275-02C9-4E55-ADEC-B2769A3C90FF Q27335093-49CF6679-EB30-4ACF-AE02-6F35355A3C3A Q28072328-4FC078C8-B92C-4F54-8435-FB598308E104 Q28073775-E3AB64FC-7AA3-4CF3-AA44-AE34687579CD Q28542960-326E3672-D9EF-4FD9-89FB-301103C1EDB8 Q30249162-D1FA6038-D33D-47FA-BB3D-6A80FA0449A4 Q30368343-530E7E8A-91C1-4EC1-86E8-CD4372A5AA04 Q30413910-5E15EBA2-96DE-4527-B596-C9C34A4B2959 Q30417544-D9A67963-FC7F-466A-914A-3A36B283C521 Q30433792-5E42B52D-86B9-47E2-B59A-E1C488430D00 Q30450128-A4B4CACC-E121-4297-B8D5-047F3C513E71 Q30458670-2A2AC81C-A7AE-4B9A-BB5F-A15AB4A0698D Q30488666-DCFEF533-622C-4E66-97EF-1C12DAABEF76 Q30764782-DFFD899F-0806-48E8-8673-23DE897B1DE7 Q30843218-D6068FB9-52EA-4913-974C-43EE8FB82120 Q30987913-CDED1468-3056-4A98-84B9-28C3E2B516BD Q31110115-02D70E2B-1B8F-44A0-BAE4-B2DF6D3DDECD Q33641970-791C15F7-5C60-45CA-9733-0A516EAB5B1F Q33662499-1D6364B1-28EE-42D9-B132-108FDE65E8E9 Q33709642-400CF7E8-75AD-4B70-A843-5649878FFE17 Q33739095-4A95AC60-0D5B-4B47-B04A-F73193564AFE Q33762340-EAB12A17-C1BC-42C6-BA1D-93B110EF7150 Q33823685-00BB9AE0-3317-469B-9A1B-405468B511C9 Q33871847-74F43F07-4A86-4741-8763-A9FEA31DB282 Q33897303-9BEA028B-0840-46A5-ACB2-9DAE01E65353 Q33959807-D25816A9-D6A1-41F0-89E3-73F538C95193

P2860

Update on AUA guideline on the management of benign prostatic hyperplasia.

http://www.wikidata.org/entity/Q44411654

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Update on AUA guideline on the management of benign prostatic hyperplasia.

@en

Update on AUA guideline on the management of benign prostatic hyperplasia.

@nl

type

label

Update on AUA guideline on the management of benign prostatic hyperplasia.

@en

Update on AUA guideline on the management of benign prostatic hyperplasia.

@nl

prefLabel

Update on AUA guideline on the management of benign prostatic hyperplasia.

@en

Update on AUA guideline on the management of benign prostatic hyperplasia.

@nl

P1433

Q44411654-9E884899-1568-4C98-9AEF-637DAF1FBFDF

P1476

Q44411654-0D983A6B-3C58-4E85-9C5D-3A2AEBA640CB

P2093

Q44411654-028EBA7C-403F-4D10-874D-CF2955003AEF

Q44411654-0C05FEC1-7B97-4E7F-8B3D-38C5AC9F94E5

Q44411654-17C2A879-5462-46E9-8DA5-49619989B5C5

Q44411654-35AC8A6F-9405-4BBD-A188-8BE2D3E16E44

Q44411654-4EBC5DEC-B31B-4CD5-B068-1CD4397B68D3

Q44411654-8FC14BA3-AA88-49C8-9E3A-1CC4FDECFB71

Q44411654-D6FD630F-464E-48FC-862D-822C99882A34

Q44411654-E96B8A7D-FFFD-469C-B4D7-71E307B24F12

Q44411654-F5984AF5-1378-4738-BBEB-D4AC21F170E8

Q44411654-FDDC4A41-5144-450C-BA0A-7C8AD9E253F5

P304

Q44411654-F793F007-E199-43A2-8E79-B496A330980C

P31

Q44411654-FFB95517-23E5-4237-A3D8-32A993F0022B

P356

Q44411654-EABA2FAD-F7E4-4EEE-A442-485CB8B80D79

P407

Q44411654-2B1AF118-A73B-486D-8AB4-D80832122637

P433

Q44411654-93FE873B-23D2-4E6C-8775-FED54B559EB4

P478

Q44411654-37379650-BDA9-49C0-9527-361DC6D47EFB

P50

Q44411654-6E907D72-1A48-4241-A881-0AAD0BC3E23E

P577

Q44411654-04394CA6-C869-4687-972D-AA8C4E23EA8A

P698

Q44411654-500737A3-8947-4216-A0D5-CA7E5F1781DD

P356

J.JURO.2011.01.074

P1433

The Journal of Urology

P1476

Update on AUA guideline on the management of benign prostatic hyperplasia.

@en

P2093

Andrew L Avins

http://www.w3.org/2001/XMLSchema#string

Chris M Gonzalez

http://www.w3.org/2001/XMLSchema#string

Claus G Roehrborn

http://www.w3.org/2001/XMLSchema#string

Harris E Foster

http://www.w3.org/2001/XMLSchema#string

James C Ulchaker

http://www.w3.org/2001/XMLSchema#string

John T Wei

http://www.w3.org/2001/XMLSchema#string

Kevin T McVary

http://www.w3.org/2001/XMLSchema#string

Michael J Barry

http://www.w3.org/2001/XMLSchema#string

Reginald C Bruskewitz

http://www.w3.org/2001/XMLSchema#string

Robert F Donnell

http://www.w3.org/2001/XMLSchema#string

P304

1793-1803

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JURO.2011.01.074

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

185

http://www.w3.org/2001/XMLSchema#string

P50

David F. Penson

P577

2011-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21420124

http://www.w3.org/2001/XMLSchema#string